autologous adipose stem cell therapy (Johns Hopkins University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous adipose stem cell therapy (Johns Hopkins University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsObstetric Labor, Premature
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsObstetric Labor, Premature

Other Information

ATC CodeN/A
Related LinksN/A